T&R Biofab Decides on 26 Billion KRW Paid-in Capital Increase

[Asia Economy Reporter Minwoo Lee] T&R Biofab announced on the 29th that it will conduct a third-party allotment paid-in capital increase worth 26 billion KRW to raise facility and operating funds.

The convertible preferred shares to be issued through the paid-in capital increase amount to 1,992,330 shares. This corresponds to approximately 23.73% of the total shares issued before the capital increase (8,395,640 shares). The lock-up period is one year.